DCCR (diazoxide choline) extended-release tablets
C615
Phase 2 small_molecule active
Quick answer
DCCR (diazoxide choline) extended-release tablets for SH2B1 Deficiency Obesity is a Phase 2 program (small_molecule) at SOLENO THERAPEUTICS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- SOLENO THERAPEUTICS INC
- Indication
- SH2B1 Deficiency Obesity
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active